J. Erik Busby

2.7k total citations
27 papers, 1.1k citations indexed

About

J. Erik Busby is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, J. Erik Busby has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Urology. Recurrent topics in J. Erik Busby's work include Bladder and Urothelial Cancer Treatments (10 papers), Urinary and Genital Oncology Studies (8 papers) and Prostate Cancer Treatment and Research (7 papers). J. Erik Busby is often cited by papers focused on Bladder and Urothelial Cancer Treatments (10 papers), Urinary and Genital Oncology Studies (8 papers) and Prostate Cancer Treatment and Research (7 papers). J. Erik Busby collaborates with scholars based in United States and Australia. J. Erik Busby's co-authors include Curtis A. Pettaway, Ashish M. Kamat, Surena F. Matin, Gordon Brown, H. Barton Grossman, Colin P. Dinney, Mark F. Munsell, Christopher P. Evans, Philippe E. Spiess and Lance C. Pagliaro and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Journal of Urology.

In The Last Decade

J. Erik Busby

27 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Erik Busby United States 16 582 350 263 211 207 27 1.1k
A. Giannopoulos Greece 18 430 0.7× 244 0.7× 231 0.9× 126 0.6× 260 1.3× 57 1.1k
Tomáš Hanuš Czechia 16 227 0.4× 220 0.6× 263 1.0× 255 1.2× 180 0.9× 72 745
Shoji Samma Japan 15 237 0.4× 258 0.7× 162 0.6× 80 0.4× 189 0.9× 81 664
Michael Aitchison United Kingdom 19 293 0.5× 444 1.3× 49 0.2× 181 0.9× 395 1.9× 45 866
F.H. Schr�der Netherlands 16 183 0.3× 673 1.9× 118 0.4× 181 0.9× 123 0.6× 19 858
H.M. Bruins Netherlands 14 1.4k 2.5× 343 1.0× 582 2.2× 52 0.2× 233 1.1× 24 1.7k
С Х Аль-Шукри Russia 9 93 0.2× 387 1.1× 471 1.8× 381 1.8× 270 1.3× 67 952
Martine Ploeg Netherlands 10 872 1.5× 131 0.4× 299 1.1× 20 0.1× 281 1.4× 14 1.1k
Łukasz Zapała Poland 15 234 0.4× 158 0.5× 91 0.3× 27 0.1× 146 0.7× 69 600
Motoyuki Masai Japan 19 102 0.2× 686 2.0× 69 0.3× 60 0.3× 320 1.5× 62 1.0k

Countries citing papers authored by J. Erik Busby

Since Specialization
Citations

This map shows the geographic impact of J. Erik Busby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Erik Busby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Erik Busby more than expected).

Fields of papers citing papers by J. Erik Busby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Erik Busby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Erik Busby. The network helps show where J. Erik Busby may publish in the future.

Co-authorship network of co-authors of J. Erik Busby

This figure shows the co-authorship network connecting the top 25 collaborators of J. Erik Busby. A scholar is included among the top collaborators of J. Erik Busby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Erik Busby. J. Erik Busby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, John T., Ziding Feng, Alan W. Partin, et al.. (2014). Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?. Journal of Clinical Oncology. 32(36). 4066–4072. 206 indexed citations
2.
Smith, Angela B., Mathew Raynor, Christopher L. Amling, et al.. (2011). Multi-Institutional Analysis of Robotic Radical Cystectomy for Bladder Cancer: Perioperative Outcomes and Complications in 227 Patients. Journal of Laparoendoscopic & Advanced Surgical Techniques. 22(1). 17–21. 79 indexed citations
3.
El-Galley, Rizk, et al.. (2011). 1843 ROBOTIC VERSUS OPEN RADICAL CYSTECTOMY: IDENTIFICATION OF PATIENTS WHO MOST BENEFIT FROM THE ROBOTIC APPROACH. The Journal of Urology. 185(4S). 1 indexed citations
4.
Svatek, Robert S., Mark F. Munsell, Paul K. Hegarty, et al.. (2009). Association Between Lymph Node Density and Disease Specific Survival in Patients With Penile Cancer. The Journal of Urology. 182(6). 2721–2727. 40 indexed citations
5.
Busby, J. Erik, et al.. (2009). Salvage therapy for prostate cancer recurrence after radiation therapy. Current Urology Reports. 10(3). 199–205. 11 indexed citations
6.
Yang, Joy C., et al.. (2008). Aberrant Activation of Androgen Receptor in a New Neuropeptide-Autocrine Model of Androgen-Insensitive Prostate Cancer. Cancer Research. 69(1). 151–160. 57 indexed citations
7.
Busby, J. Erik, Gordon Brown, & Surena F. Matin. (2008). Comparing Lymphadenectomy During Radical Nephroureterectomy: Open Versus Laparoscopic. Urology. 71(3). 413–416. 26 indexed citations
8.
Brown, Gordon, Surena F. Matin, J. Erik Busby, et al.. (2007). Ability of Clinical Grade to Predict Final Pathologic Stage in Upper Urinary Tract Transitional Cell Carcinoma: Implications for Therapy. Urology. 70(2). 252–256. 81 indexed citations
9.
Busby, J. Erik & Surena F. Matin. (2007). Laparoscopic radical nephroureterectomy for transitional cell carcinoma: where are we in 2007?. Current Opinion in Urology. 17(2). 83–87. 9 indexed citations
10.
Brown, Gordon, J. Erik Busby, Christopher G. Wood, et al.. (2006). Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm?. British Journal of Urology. 98(6). 1176–1180. 100 indexed citations
11.
Busby, J. Erik, Gordon Brown, Pheroze Tamboli, et al.. (2006). Upper urinary tract tumors with nontransitional histology: A single-center experience. Urology. 67(3). 518–523. 66 indexed citations
12.
13.
Izawa, Jonathan I., et al.. (2006). Histological changes in prostate biopsies after salvage cryotherapy: effect of chronology and the method of biopsy. British Journal of Urology. 98(3). 554–558. 12 indexed citations
14.
Busby, J. Erik & Curtis A. Pettaway. (2005). What's new in the management of penile cancer?. Current Opinion in Urology. 15(5). 350–357. 27 indexed citations
15.
Yazıcı, Sertaç, Seung Jun Kim, J. Erik Busby, et al.. (2005). Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice. The Prostate. 65(3). 203–215. 30 indexed citations
16.
Busby, J. Erik & Roger K. Low. (2004). Ureteroscopic treatment of renal calculi. Urologic Clinics of North America. 31(1). 89–98. 25 indexed citations
17.
Busby, J. Erik & Christopher P. Evans. (2004). Determining variables for repeat prostate biopsy. Prostate Cancer and Prostatic Diseases. 7(2). 93–98. 14 indexed citations
18.
Evans, Christopher P. & J. Erik Busby. (2003). The management of stage T1 grade 3 transitional cell carcinoma of the bladder. British Journal of Urology. 92(4). 345–348. 5 indexed citations
19.
Busby, J. Erik, et al.. (2003). Angiogenesis is not Mediated by Prostate Cancer Neuropeptides. Angiogenesis. 6(4). 289–293. 9 indexed citations
20.
Busby, J. Erik, et al.. (1991). A longitudinal study of osteoarthritis of the hand: the effect of age. Annals of Human Biology. 18(5). 417–424. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Giannopoulos Breakdown of academic impact, for papers by Tomáš Hanuš Breakdown of academic impact, for papers by Shoji Samma Breakdown of academic impact, for papers by Michael Aitchison Breakdown of academic impact, for papers by F.H. Schr�der Breakdown of academic impact, for papers by H.M. Bruins Breakdown of academic impact, for papers by С Х Аль-Шукри Breakdown of academic impact, for papers by Martine Ploeg Breakdown of academic impact, for papers by Łukasz Zapała Breakdown of academic impact, for papers by Motoyuki Masai
Rankless by CCL
2026